Laboratory diagnosis and surveilance of heparin-induced thromobocytopenia;Diagnostic et surveillance biologique des thrombopenies induites par l'heparine

Presse Medicale

Volumn 27, Issue SUPPL. 2, 1998, Pages 13-17

  Nguyen P ^a  

^a SERVICE DE DERMATOLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DANAPAROID; HEPARIN; LEPIRUDIN; THROMBOCYTE FACTOR 4;

CONFERENCE PAPER; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG INDUCED DISEASE; HUMAN; LABORATORY DIAGNOSIS; PARTIAL THROMBOPLASTIN TIME; SUBSTITUTION THERAPY; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA;

ANTICOAGULANTS; FRANCE; HEPARIN; HUMANS; MONITORING, PHYSIOLOGIC; PLATELET AGGREGATION; PLATELET COUNT; THROMBOCYTOPENIA;

EID: 3543045519     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Recommandations du Groupe d'Etudes sur l'Hémostase et la Thrombose (GEHT). Utilisation des héparines en pratique médicale courante. STV 1996 ; 8:5-13.
2. Fratantoni JC, Pollet R, Gralnick HR. Heparin-induced thrombocytopenia : confirmation of diagnosis with in vitro methods. Blood 1975 ; 45:395-401.
3. Nguyên P, Lecompte T and Groupe d'Etude sur l'Hémostase et la Thrombose (GEHT) de la Société Française d'Hématologie. Heparin-induced thrombocytopenia : a survey of tests employed and attitudes in haematology laboratories. Nouv Rev Fr Hematol 1994 ; 36:353-7.
4. Kelton JG, Sheridan D, Brain H, Powers PJ, Turpie AG, Carter CJ. Clinical usefulness of testing for a heparin-dependent platelet-aggregating factor in patients with suspected heparin-associated thrombocytopenia. J Lab Clin Med 1984; 103:606-12.
5. Stewart MW, Etches WS, Boshkov LK, Gordon PA. Heparin-induced thrombocytopenia : an improved method of detection based in lumi-aggregometry. Br J Hoemotol 1995; 91:173-7.
6. Lee DH, Warkentin TE, Denomme GA, Hayward CPM, Kelton JG. A diagnostic test for heparin-induced thrombocytopenia : detection of platelet microparticles using flux cytometcy. Br J Haematol 1996 ; 95:724-31.
7. Tomer A. A sensitive and specific functional flow cytometric assay for the diagnosis of heparin-induced thrombocytopenia. Br J Haematol 1997 ; 98:648-56.
8. Mao WW, Jy W, Kolodny L, Horstman L, Valant P, Ahn YS. Discrimination of heparin-induced thrombocytopenia (HIT) from HIT with thrombosis (HITT) by flow cytometric analysis of activation marker CD62P. Thromb Haemost 1997 ; 448S.
9. Fareed J, Yang L, Blakemore C et al. Glycoprotein IIb/IIIa inhibitors can prevent heparin mediated platelet activation in heparin-induced thrombocytopenia. Thromb Haemost 1997 ; 362S.
10. Hérault JP, Lalé A, Savi P, Pflieger AM, Lormeau JC, Herbert JM. In vitro inhibition of heparin-induced platelet aggregation in plasma from patients with HIT by SR 121566, a newly developed GPIIbIIIa antagonist. Thromb Haemost 1997 ; 363S.
11. Amiral J, Bridey F, Dreyfus M et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin induced thrombocytopenia. Thromb Haemost 1992 ; 68:95-6.
12. Amiral J, Marfaing-Koka A, Wolf M et al. Presence of auto-antibodies to interleukin-8 or neutrophil activating peptide-2 in patients with heparin-associated-thrombocytopenia. Blood 1996 ; 88:410-6.
13. Amiral J, Wolf M, Fischer AM, Boyer-Neumann C, Vlssac AM, Meyer D. Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia. Br J Haematol 1996 ; 92:954-9.
14. Pouplard C, May MA, Delahousse B et al. Development of antibodies specific to PF4/heparin complexes in patients undergoing cardio-pulmonary bypass. Thromb Haemost 1997 ; 448S.
15. Trossaërt M, Gaillard A, Comin PL, Vissac AM, Amiral J. High frequency of anti-heparin/PF4 antibodies in cardiopulmonary bypass. Thromb Haemost 1997 ; 449S.
16. Magnani HN. Heparin-induced thrombocytopenia (HIT): an overview of 230 patients treated with orgaran (Org 10172). Thromb Haemost 1993 ; 70:554-61.
17. Tripodi A, Chantarangkul V, Arbini AA, Moia M, Mannucci PM. Effects of hirudin on activated partial thromboplastin time determined with ten different reagents. Thromb Haemost 1993; 70:286-8.
18. Pötzsch B, Madlener K, Seelig C, Riess C, Greinacher A, Müller-Berghaus G. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass - assessment of the whole blood ecarin clotting time. Thromb Haemost 1997; 77:920-5.